Jump to main content
Jump to site search

Issue 5, 2017
Previous Article Next Article

An insight into the therapeutic potential of quinazoline derivatives as anticancer agents

Author affiliations

Abstract

Cancer is one of the major causes of worldwide human mortality. A wide range of cytotoxic drugs are available on the market, and several compounds are in different phases of clinical trials. Many studies suggest that these cytotoxic molecules are also associated with different types of adverse side effects; therefore researchers around the globe are involved in the development of more efficient and safer anticancer drugs. In recent years, quinazoline and its derivatives have been considered as a novel class of cancer chemotherapeutic agents that show promising activity against different tumors. The aim of this article is to comprehensively review and highlight the recent developments concerning the anticancer activity of quinazoline derivatives as well as offer perspectives on the development of novel quinazoline derivatives as anticancer agents in the near future.

Graphical abstract: An insight into the therapeutic potential of quinazoline derivatives as anticancer agents

Back to tab navigation

Publication details

The article was received on 25 Feb 2017, accepted on 05 Apr 2017 and first published on 07 Apr 2017


Article type: Review Article
DOI: 10.1039/C7MD00097A
Citation: Med. Chem. Commun., 2017,8, 871-885
  •   Request permissions

    An insight into the therapeutic potential of quinazoline derivatives as anticancer agents

    Shagufta and I. Ahmad, Med. Chem. Commun., 2017, 8, 871
    DOI: 10.1039/C7MD00097A

Search articles by author

Spotlight

Advertisements